Pharmaceutical raw material Stugeron CAS 298-57-7

Other Name：

1-benzhydryl-4-trans-cinnamylpiperazine; Cinnarazine; 

1-(diphenylmethyl)-4-[(1E)-3-phenylprop-1-en-1-yl]piperazine;

Cinnarizine; Cinnarizinum

CAS Number：

298-57-7

EINECS Number：

206-064-8

Molecular Formula：

C26H28N2

Molecular Weight：

368.5139

InChI：

InChI=1/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-12,14-18,26H,13,19-22H2/b18-10+

Appearance:

White crystalline powder

Purity:

≥ 99%

Density：

1.125g/cm3

Melting Point:

117-120°C

Boiling Point：

488.83°C

Flash Point：

228.1°C

Vapour Pressure：

2.35E-10mmHg at 25°C

Refractive Rate:

1.7620

Storage Condition:

Sealed in dry,2-8°C

Solubility:

Soluble in chloroform at 50mg/ml

pKa:

7.47(H2Ot=25.0)

Water Solubility:

0.75g/L

Merck:

14,2305

Application:

Used as Long acting multifunctional vasoconstrictor antagonist, it can dilate blood vessels, 

improve blood circulation and prevent vascular embrittlement. 

It can also be used to treat cerebrovascular diseases, headache, dizziness, insomnia, memory loss,

 hemiplegia, limb numbness and weakness, unclear speech and other diseases caused by cervical vertigo.